Background: Retrocalcaneal bursitis is the inflammation of the bursa between the anterior aspect of the Achilles and posterior aspect of the calcaneum which is associated with achilles tendinitis, plantar fasciitis, calcaneal spurs, fibromyalgia and rheumatoid arthritis.
Introduction
Retrocalcaneal bursitis is the inflammation of the bursa between the anterior aspect of the Achilles and posterior aspect of the calcaneum which is most commonly seen in professional athletes. Retrocalcaneal bursitis is also associated with achilles tendinitis, plantar fasciitis, calcaneal spurs, fibromyalgia and rheumatoid arthritis [1] . The embryological origin of the plantar fascia seems to be united with the Achilles tendon [2] and this connection comprises a layer of periosteal fibers that declines in thickness and elastic properties with aging [3] . The ubiquitous presence of hyaluronate within plantar fascia enables the gliding of fibrous bundles and acts as an an efficient shock absorber and also serving an anti-inflammatory purpose [4] . The chondrocytes found near the heel insertion expresses a cartilaginous metaplasia that gradually reduces the connection between the Achilles tendon and the plantar fascia, reducing PF elasticity as a consequence [5] . The strong correlation between the thickness of plantar fascia and Achilles paratenon suggest in the case of plantar fascia thickening the characteristics of Achilles tendon and paratenon should also be evaluated. The patients with retrocalcaneal bursitis and its associations are unaware of the need for prompt treatment to prevent further complications. The various modalities of management of retrocalcaneal bursitis are pharmacological management, physical therapy, biological therapy and surgical management.
Objectives
To prospectively review a series of patients who have been treated with biological treatment with autologous platelet rich plasma injections for symptomatic retrocalcaneal bursitis and its associations to determine if PRP injections (1) provide symptomatic relief, (2) improved the visual analogue scale (VAS) score and functional AOFAS scores and (3) alleviation of need of surgery. 
Materials and Methods
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cases were taken up for this study who were treated with autologous platelet rich plasma injection as per our study protocol.
 The clinical entities involved in this study were retrocalcaneal bursitis with achilles tendinitis (n=37), retrocalcaneal bursitis (n=51) and retrocalcaneal bursitis with plantar fasciitis (n=40). 
Results
The data obtained from the participants of the study were subjected to repeated measures ANOVA test and the following results are obtained. The demographic details (Table 1) , the number of PRP injections given to alleviate the disease (Table 2) , the statistical analysis (Table 3 ) and the complications ( 
Discussion
There is a strong positive correlation and temporal association existing between the occurrence of plantar fasciitis, retrocalcaneal bursitis and achilles tendinopathy [1, 6] .
Retrocalcaneal bursitis and Haglund deformity
Retrocalcaneal bursitis is the inflammation of the bursa between the anterior aspect of the Achilles and posterior aspect of the calcaneum. In some cases, retrocalcaneal bursitis may be caused by bursal impingement between the Achilles tendon and an excessively prominent posterosuperior aspect of the calcaneus (Haglund deformity). In
Haglund disease, impingement occurs during ankle dorsiflexion. Retrocalcaneal bursitis is also associated with achilles tendinitis, plantar fasciitis, calcaneal spurs, fibromyalgia and rheumatoid arthritis. In retrocalcaneal bursitis, the pain is localized to anterior and 2 to 3 cm proximal to the achilles tendon insertion, pain with dorsiflexion and a bony prominence at achilles insertion [6] .
Achilles tendinopathy
Achilles tendinopathy occurs in middle-aged and elderly patients with a tight heel cord. The mechanism of achilles tendinopathy is due to repetitive trauma leads to inflammation followed by cartilaginous and bony metaplasia, 
Plantar fasciitis
Plantar fasciitis is a chronic self-limiting condition due to overuse of plantar fascia, which is characterized by micro tears, the breakdown of collagen, and scarring. Between 4% and 7% of people have heel pain at any given time and about 80% of these cases are due to plantar fasciitis. The pain is usually most severe with the first steps of the day or following a period of rest. Pain is also frequently brought on by bending the foot and toes up towards the shin and may be worsened by a tight achilles tendon. In about a one-third of the population, both legs are affected. Most common site of abnormality in patients with plantar fasciitis is near the origin or enthesitis of the central band of plantar aponeurosis at medial plantar tubercle of calcaneus. Patient walk with an equinus gait to avoid placing pressure on painful heel. On examination, tenderness on the medial plantar calcaneal region as a sharp stabbing pain is felt. Passive ankle or first toe dorsiflexion elicits pain. When plantar fasciitis is bilateral, it is associated with rheumatoid arthritis, SLE and gout [7] .
Platelet rich plasma, a potent "Orthobiologic", is defined as the volume of supernatant containing plasma with platelet concentration of 10 5 -10 6 above the baseline, which is a potent osteogenic, osteointegrative and osteorejuvenative agent [8] . The rationale behind platelet rich plasma in the management of retrocalcaneal bursitis 
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and its associations are due to the interplay between histopromotive factors and rejuvenating micromolecules present in the platelets. The binding of growth factor to target cell receptor induces a signal transduction mechanism which produces chemotaxis, cell proliferation and osteoblastic differentiation [9] . The growth factors undergo tyrosine autophosphorylation to catabolise the further phosphorylation of other growth factors [10] [11] [12] . In this article, we considered autologous platelet rich plasma injection as the biological and minimally invasive therapeutic option for retrocalcaneal bursitis and its associations. Which show the functional improvement in 76 patients (59.37%) with 1 st dose of autologous PRP injection and a further 38 patients (29.68%) with 2 nd dose of autologous PRP injection with an interval of 3 weeks from the first dose. A total of 89.05% of patients, who got treated with autologous PRP injection, had a good clinical and functional outcome even at the end of 1 year of injections and presented with statistically significant results with a p value <0.001.
Limitation
 No comparison group was considered in the study  Standardization of PRP injection protocol has to be figured out.
Conclusion
Though the literatures available for autologous PRP therapy for retrocalcaneal bursitis are very less, we tried evaluating the efficacy and durability of autologous PRP therapy for retrocalcaneal bursitis and its associations which proved to improve the quality of pain and functional quality of life. Hence, we conclude the biological therapeutics of platelet rich plasma for retrocalcaneal bursitis is more beneficial than other pharmacological 
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